Main Campus Inpatient Internship Program
Purpose
The purpose of the Cleveland Clinic Main Campus inpatient pharmacy internship program is to prepare interns to become pharmacy practitioners that embody excellence in education, clinical care, and personal integrity. This program challenges student pharmacists to think creatively and critically while emphasizing a wide range of backgrounds, innovation, and the commitment to putting patients first.
The program will prepare interns well not only for health-system pharmacy roles, but as practitioners and stewards of the pharmacy profession upon graduation from pharmacy school.
Program details
Our program is a year-round paid internship consisting of a 12-week full-time summer component from May-August, and one out of every four weekends throughout the academic year. This longitudinal experience will span over three years, with summer blocks after P1 and P2 spring semesters. The first summer will consist of training in pharmacy operations. The second summer will consist of clinical rotations in areas such as internal medicine, cardiology, emergency medicine, critical care, pediatrics, infectious disease, oncology, transplant, ambulatory care, management, neurology and informatics. Additional areas may be available based on intern interest and preceptor availability.
Info sessions
September 24, 2026 from 7-8 p.m.
Join session
Meeting ID: 211 501 537 734 744
Passcode: 8yf2gS7D
October 1, 2026 from 5-6 p.m.
Join session
Meeting ID: 265 600 530 679 413
Passcode: XK3rP6nN
Eligibility
In order to be eligible for selection, students must be in their first or second year of professional pharmacy education within an ACPE-accredited Doctor of Pharmacy program (either 1st/2nd year student in a 4-year program or 3rd/4th year student in a 6-year program). All applicants must be eligible for an intern license in the state of Ohio. If selected, the student will be required to obtain their license by April 1, 2027. Interns with scheduling conflicts due to summer IPPE requirements must be able to commit to a minimum of 10 weeks on-site during each summer in order to be eligible to apply for the program. Candidates should be available for a 30 minute interview in October.
Cleveland Clinic is pleased to be an equal opportunity employer. All applicants will be considered regardless of race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status. Cleveland Clinic is a smoke-free/drug-free environment.
Applications
The deadline to apply is October 9, 2026.To be considered, applicants must submit an online application via the Cleveland Clinic Careers webpage, a letter of intent describing their interest in the program, a CV or resume, and a letter of recommendation. Incomplete applications will not be reviewed.
All required documents must be submitted as one document in PDF format except for the letter of recommendation. Instruct letter writer to e-mail the letter directly to Stevie Allen (allens33@ccf.org) and Allie Brant (branta@ccf.org) with the subject: LAST NAME, FIRST NAME Intern LOR. Please note: this application will be for the pharmacy internship at Cleveland Clinic Main Campus only.
Contact
Allie Brant, PharmD, MS, BCPS
Inpatient Pharmacy Manager, Internal Medicine and Intern Program
Department of Pharmacy
9500 Euclid Ave
Cleveland, OH 44195
Email: branta@ccf.org
Regional Inpatient Internship Program
Purpose
The purpose of the Cleveland Clinic inpatient pharmacy internship program is to prepare interns to become pharmacy practitioners that embody excellence in education, clinical care, and personal integrity. This program challenges student pharmacists to think creatively and critically while emphasizing a wide range of backgrounds, innovation, and the commitment to putting patients first.
The program will prepare interns well not only for health-system pharmacy roles, but as practitioners and stewards of the pharmacy profession upon graduation from pharmacy school.
Program details
Learn more about internship opportunities at our regional hospitals by downloading the brochures below:
Eligibility
To be eligible for selection, students must be in an ACPE-accredited Doctor of Pharmacy program. All applicants must be eligible for an intern license in the state of Ohio.
Cleveland Clinic is pleased to be an equal opportunity employer. All applicants will be considered regardless of race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status. Cleveland Clinic is a smoke-free/drug-free environment.
Applications
Applicants can view available positions and apply via the Cleveland Clinic Careers webpage. Applicants should submit a CV and are encouraged to submit a letter of intent and at least one (1) letter of recommendation. Recommendation letters should be in PDF format and must be signed by the author.
Community Pharmacy Internship Program
Purpose
The purpose of the community pharmacy summer internship program is to develop knowledge and skills in community pharmacy to assist with patient transition from hospital to ambulatory pharmacy care.
Program details
Community Pharmacy interns will rotate through a variety of outpatient pharmacy settings within the Cleveland Clinic enterprise including main campus, family health centers, and outpatient pharmacies within community hospitals. Experiences may include: patient consultation, technical functions, medication therapy management, specialty medication services, technology development, and quality assurance.
Additional requirements may vary by site:
- Avon Outpatient (Richard E. Jacobs FHC)
- Beachwood FHC
- Cleveland Clinic Administrative Campus
- Euclid Ave. Pharmacy (Main Campus)
- Euclid Ave. Pharmacy (Main Campus) – Medication Access Coordinator Team
- Twinsburg FHC
- Willoughby Hills FHC
Eligibility
To be eligible for selection, students must be in an ACPE-accredited Doctor of Pharmacy program. All applicants must be eligible for an intern license in the state of Ohio.
Applications
Applicants can view available positions and apply via the Cleveland Clinic Careers webpage. Applicants should submit a CV and are encouraged to submit a letter of intent and at least one (1) letter of recommendation. Recommendation letters should be in PDF format and must be signed by the author.
Examples of Student Longitudinal Projects
- Evaluation of inpatient administration of medications that should be given in HOP setting only (e.g., infliximab, select chemo, etc.).
- Develop and implement a patient satisfaction survey for the anticoagulation clinics.
- Develop weekly communication regarding formulary changes, drug shortages and alternatives, and drug recalls, or any other pertinent information from the FDA, etc.
- IVIG drug usage evaluation in BMT population.
Completed Intern Project Abstract
Moxifloxacin Drug Use Evaluation
Purpose
Moxifloxacin was added to the Cleveland Clinic Formulary in July 2008. It is restricted to penicillin-allergic patients with community-acquired pneumonia (CAP). Ceftriaxone plus azithromycin is the preferred treatment for CAP. Limiting fluoroquinolone use may assist with preventing the emergence of quinolone-resistant isolates. In addition quinolone use, especially moxifloxacin, has been reported with increased C. difficile rates. Therefore, determining if moxifloxacin is prescribed appropriately is important to reduce the possibility of resistance and C. difficile infections.
Methods
A concurrent, non-interventional chart review of patients prescribed moxifloxacin from January 2010-June 2010 was performed. The Cleveland Clinic electronic medical records system (EPIC) was utilized to review and analyze a sample of these patients. Any patient 18 years of age and older who received moxifloxacin was included in the study. Patients treated in the Emergency Department or for tuberculosis (TB) or non-mycobacterial TB were excluded. Data collected included: age, gender, nursing unit, penicillin allergy, type of allergic reaction if applicable, indication for moxifloxacin use, initial formulation of medication, duration of therapy, Infectious Disease consult, and other antimicrobial agents.
Results
165 patients were prescribed moxifloxacin during the time period. 70 patients were reviewed. 18 patients were excluded: four did not receive the medication, 13 were treated in the emergency department, and one was treated for Mycobacteria tuberculosis. A total of 52 patients were analyzed. The average age of the patients was 61 years (± 14 years). The median length of stay (LOS) was nine days (2-36 days). 28 patients were allergic to penicillin with the most common reactions of: rash/itching (nine), hives (five), and anaphylaxis (four). 16 patients were correctly prescribed moxifloxacin (30.7%) according to the restriction. 36 patients did not meet the restriction criteria; the most common indications were: CAP/presumed CAP with no penicillin allergy (13), HAP/HCAP (eight), sinusitis (five), COPD exacerbation (three), and bronchitis (two). In the non-adherence group, the median duration of therapy was three days (1-16 days). Seven non-adherence patients only received one dose and 29 patients were discharged on moxifloxacin. Infectious Disease was consulted for 19 of the non-adherence patients (53%).
Conclusion
Overall adherence to the restriction appears poor (30.7%). However, a significant portion of use was for patients with penicillin allergies and upper respiratory tract infections. Consideration should be given to expanding the restriction criteria to include other URTIs (e.g., sinusitis, bronchitis) in penicillin allergic patients. Another significant use in the non-adherence group was for the treatment of HAP/HCAP. Ciprofloxacin is the quinolone of choice in this infection due to improved Pseudomonal activity. Finally, the type of penicillin allergy needs to be taken into consideration. Ceftriaxone and azithromycin may be used for non-severe reaction (e.g., rash). Moxifloxacin should not be used when the listed allergy is adverse reaction (e.g. nausea). Education should be provided to the health care team on these matters.
